Ligustrazine nanoparticles inhibits epithelial-mesenchymal transition and alleviates postoperative abdominal adhesion
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Shasha Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Teaching and Research Office of Obstetrics and Gynecology, Medical College of Zhengzhou University of Industrial Technology, Xinzheng, 451100, Henan,…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Rats, Sprague-Dawley, Nanoparticles, Pyrazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Province Natural Science Foundation, China Postdoctoral Science Foundation, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Following abdominal surgery, the occurrence of postoperative abdominal adhesion (PAA) is highly prevalent and stands out as one of the most frequently encountered complications. The effect and molecular mechanisms of Ligustrazine nanoparticles (LN) underlying epithelial-mesenchymal transition (EMT) in PAA still remain elusive. Adhesions were induced in Male Sprague-Dawley rats by injuring the cecum (cecal abrasion model), followed by administration of LN and hyaluronate acid (HA). The mechanism was further verified by enzyme-linked immunosorbent assay, wound healing assay, si-RNA and Western blot. Animal experiments revealed that LN effectively ameliorated adhesions, notably decreased tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-8, and fibrosis, and reduced the expression of TGF-β1 and EMT related markers (Fibronectin and E-cadherin). Furthermore, in vitro experiments demonstrated that LN might inhibit the TGF-β1 FOXC2 pathway through suppressing the expression of Fibronectin, P120, and E-cadherin and ameliorating peritoneal adhesion. Collectively, our findings indicate that LN inhibits PAA formation by reducing inflammation, decreasing EMT and promoting peritoneal mesothelial cell repair. Therefore, LN might be considered a potential candidate for the treatment of PPA. However, further clinical studies are required to approve the effectiveness of LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Teaching and Research Office of Obstetrics and Gynecology, Medical College of Zhengzhou University of Industrial Technology, Xinzheng, 451100, Henan, China.
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
- Department of Gynaecology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009, Jiangsu, China.
- Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009, Jiangsu, China.
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.
- Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215009, Jiangsu, China. Electronic address: doctor_shuaiyan@njucm.edu.cn.
Förderung
- Jiangsu Province Natural Science Foundation
- China Postdoctoral Science Foundation
- Postdoctoral Research Foundation of China
Zitieren
APA
Liang, S., Qian, Y., Liu, Y., Wang, Y., Su, L., & Yan, S. (2024). Ligustrazine nanoparticles inhibits epithelial-mesenchymal transition and alleviates postoperative abdominal adhesion. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150994
Vancouver
Liang S, Qian Y, Liu Y, Wang Y, Su L, Yan S. Ligustrazine nanoparticles inhibits epithelial-mesenchymal transition and alleviates postoperative abdominal adhesion. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150994
BibTeX
@article{Liang2024,
author = {Liang, Shasha and Qian, Yifei and Liu, Ying and Wang, Yahui and Su, Lianlin and Yan, Shuai},
title = {Ligustrazine nanoparticles inhibits epithelial-mesenchymal transition and alleviates postoperative abdominal adhesion},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150994}
}
EUVIMED